-
Whole_Exome_PC9_and_A375
Study
EGAS00001002493
-
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Study
EGAS00001001479
-
RNA_expression_profiling_of_melanoma_patient_derived_xenograft
Study
EGAS00001001537
-
Genomic analysis reveals novel secondary drivers and progression pathways in skin basal cell carcinoma
Study
EGAS00001001540
-
Whole genome sequencing and whole exome sequencing of DIPG tumors and matched normal tissue
Study
EGAS00001000575
-
Genomic characterization of Malignant Pleural Mesothelioma.
Study
EGAS00001001563
-
The spatial organization of intratumor heterogeneity andevolutionary trajectories of metastases in hepatocellular carcinoma
Study
EGAS00001001603
-
Whole-genome sequencing analysis of low-grade astrocytomas within the ICGC PedBrain Tumor Project
Study
EGAS00001000381
-
Mesothelioma Genomics Study - WGS tumour/normal pairs
Study
EGAS00001002299
-
Small molecule inhibitors of LOXL synergize with 5-AZA to restore erythropoiesis in myeloid neoplasms
Study
EGAS00001006174
-
Balanced_Brain_Tumour_Whole_Genome_Sequencing
Study
EGAS00001000360
-
CMF_RNA_sequencing
Study
EGAS00001000470
-
ICGC Oesophageal adenocarcinoma - tumour samples
Study
EGAS00001000725
-
Next_gen_seq_of_eye_cancers
Study
EGAS00001002309
-
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
Study
EGAS00001000750
-
Whole genome, whole exome, and targeted sequencing of high-grade meningioma tumor samples.
Study
EGAS00001002294
-
The Immune Microenvironment, Genome–Wide Copy Number Aberrations and Survival in Mesothelioma
Study
EGAS00001002323
-
Long-read sequencing for cell-free DNA analysis (human pacbio)
Study
EGAS00001006609
-
Chondromyxoid_fibroma
Study
EGAS00001000533
-
Deep_sequencing_of_melanoma_for_driver_mutations
Study
EGAS00001000857
-
Whole genome sequencing of metastatic melanomas from a patient with primary resistance to BRAF inhibition
Study
EGAS00001000580
-
Spatio-temporal evolution of the primary glioblastoma genome
Study
EGAS00001001041
-
Comprehensive investigation of genome architecture of gastric adenocarcinoma with whole-genome sequencing in the Chinese population.
Study
EGAS00001002404
-
Whole genome sequencing identified biomarker of response to PD1 blockade in Natural-killer/T-cell lymphoma
Study
EGAS00001002420
-
Intra-tumor heterogeneity and clonal evolution patterns towards platinum-resistant high-grade serous ovarian cancer
Study
EGAS00001001244
-
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy
Study
EGAS00001001254
-
Independent development of lymphoid and histiocytic malignancies from a shared early precursor
Study
EGAS00001001353
-
Cell fate mapping of human glioblastoma reveals an invariant stem cell hierarchy pre- and post-treatment
Study
EGAS00001002424
-
The evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion
Study
EGAS00001002432
-
Successful immune checkpoint blockade in a patient with advanced stage microsatellite unstable biliary tract cancer (H021)
Study
EGAS00001002441
-
Exome Sequencing to Define the Landscape of Plasma Cells in Systemic Light chain Amyloidosis
Study
EGAS00001001418
-
Integrative genomic and transcriptomic analysis of adult leiomyosarcoma (HIPO-028, HIPO-018, HIPO-021)
Study
EGAS00001002437
-
Clonal_expansion_of_mutated_cell_population_in_bladder_urothelium_
Study
EGAS00001001687
-
Successful BRAF/MEK-inhibition in a young patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma (HIPO-021)
Study
EGAS00001004282
-
Melanoma_C32_ENU_Resistance_to_Single_Agent_Therapy
Study
EGAS00001001697
-
Linking genes, genomic instability and molecular subgroups in medulloblastoma
Study
EGAS00001000085
-
H3K27ac and RNA-seq data of neuroblastoma PDXs and/or primary tumors
Study
EGAS00001002505
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
Somatic_Variation_Angiosarcoma
Study
EGAS00001002610
-
Myeloma_Follow_up_Pilot
Study
EGAS00001000743
-
Genome-wide genetic and epigenetic dataset of pancreatic acinar cell carcinomas
Study
EGAS00001002533
-
Capture Hi-C on MM
Study
EGAS00001002614
-
Copy-number signatures and mutational processes in ovarian carcinoma
Study
EGAS00001002557
-
Sequencing_melanoma_germlines
Study
EGAS00001002081
-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Comparative genomics research for Chinese colorectal cancer
Study
EGAS00001002576
-
Roma Sequencing Study
Study
EGAS00001004287
-
Inhibiton of the GABPB1L-containing GABP tetramer is sufficient to reverse replicative immortality in TERT promoter mutant glioblastoma cells.
Study
EGAS00001002582
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
The exomic landscape of t(14,18) negative diffuse follicular lymphoma with 1p36 deletion
Study
EGAS00001002594
-
Whole Genomes Define Concordance in Matched Primary, Xenograft, and Organoid Models of Pancreas Cancer
Study
EGAS00001002597
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
The_Transcriptome_of_PLX4032_resistance
Study
EGAS00001000413
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000812
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Identification_of_drug_resistance_genes_in_melanoma_by_mRNA_gene_expression
Study
EGAS00001000815
-
Identification_of_drug_resistance_genes_in_melanoma_by_small_RNAs_expression_analysis
Study
EGAS00001000816
-
Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
Study
EGAS00001002696
-
Primary_angiosarcoma_Whole_Genome_Sequencing
Study
EGAS00001000851
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Comprehensive genomic profiling of matched glioblastoma tumours, cell-lines, and xenografts reveals genomic stability and adaptation to disparate growth environments
Study
EGAS00001002709
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_squamous_cell_carcinoma
Study
EGAS00001002725
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__pancreas
Study
EGAS00001002726
-
UK10K RARE COLOBOMA
Study
EGAS00001000127
-
We describe a method to culture organoids from adult human kidney tissue and describe applications for the culture system.
Study
EGAS00001002729
-
Targeted Gene Panel for 171 PTCLs
Study
EGAS00001002740
-
Sex-biased patterns shaped the genetic history of Roma
Study
EGAS00001004207
-
ICGC PedBrain: Deep-sequencing of childhood brain tumors.
Study
EGAS00001000215
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
Splenic_Marginal_Zone_Lymphoma_with_villous_lymphocytes_exome_sequencing
Study
EGAS00001000139
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC -- CA209-009
Study
EGAS00001004290
-
Comprehensive genetic analysis of uveal melanoma heterogeneity during metastatic progression
Study
EGAS00001002761
-
Stratifying and Targeting Pediatric Medulloblastoma through Genomics
Study
EGAS00001000273
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
Whole-genome and transcriptome sequencing of tumor-stage mycosis fungoides
Study
EGAS00001002860
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 2).
Study
EGAS00001002771
-
Whole-exome sequencing reveals the origin and evolution of Hepato-Cholangiocarcinoma
Study
EGAS00001002783
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
Whole genome study of Hurthle cell thyroid carcinoma
Study
EGAS00001000940
-
Whole exome sequencing of longitudinal samples from a melanoma patient receiving MEK plus CDK4/6 inhibitor therapy.
Study
EGAS00001002846
-
Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation
Study
EGAS00001002796
-
Genome Landscape of Primary Pancreatic Ductal Adenocarcinoma
Study
EGAS00001000154
-
Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma
Study
EGAS00001002811
-
Predictor_ChemoNEAR_TNBC
Study
EGAS00001002806
-
Genomic profiling of matched well differentiated and de-differentiated liposarcoma.
Study
EGAS00001002807
-
Molecular subtypes of malignant peritoneal mesothelioma
Study
EGAS00001002820
-
Osteosarcoma_Exome_Sequencing
Study
EGAS00001000163
-
BRAF_and_MEK_resistant_cell_line_clones
Study
EGAS00001000172
-
H3.3G34R/V-transformed interneuron progenitors co-opt PDGFRA for gliomagenesis
Study
EGAS00001004301
-
Meningioma_Exome
Study
EGAS00001000177
-
A genomic approach towards an understanding of clonal evolution and disease progression in multiple myeloma
Study
EGAS00001002850
-
Chondrosarcoma_Validation_Study
Study
EGAS00001000181
-
Targeted exome sequencing of pleomorphic invasive lobular carcinoma (PILC).
Study
EGAS00001002871
-
Integrated genetic and epigenetic analysis of myxofibrosarcoma
Study
EGAS00001002889
-
Radiotherapy_induced_sarcoma
Study
EGAS00001000138
-
Genomic Heterogeneity and the Small Renal Mass
Study
EGAS00001002919
-
Genomic landscape of IG-MYC positive Burkitt lymphoma with precursor B-cell immunophenotype.
Study
EGAS00001002968